These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 37743592)

  • 1. Epiretinal neovascular membrane in Macular Telangiectasia type 2: Multimodal imaging diagnosis.
    Rodríguez-Fernández CA; Morwani R; Arias L
    Eur J Ophthalmol; 2024 Mar; 34(2):NP13-NP16. PubMed ID: 37743592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epiretinal Neovascularization: A Novel OCT Angiography Finding in Macular Telangiectasia Type 2.
    Ayachit AG; Reddy LU; Joshi S; Ayachit GS
    Ophthalmol Retina; 2019 Jun; 3(6):516-522. PubMed ID: 31174674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multimodal Imaging of Macular Telangiectasia Type 2: Focus on Vascular Changes Using Optical Coherence Tomography Angiography.
    Toto L; Di Antonio L; Mastropasqua R; Mattei PA; Carpineto P; Borrelli E; Rispoli M; Lumbroso B; Mastropasqua L
    Invest Ophthalmol Vis Sci; 2016 Jul; 57(9):OCT268-76. PubMed ID: 27409482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epiretinal membrane formation and optic disc vascularisation in type 2A macular telangiectasia (MacTel).
    Venkatesh R; Mangla R; Handa A; Parmar Y; Sangoram R; Chhablani J
    Eur J Ophthalmol; 2024 Mar; 34(2):NP78-NP82. PubMed ID: 37644815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progression of vascular changes in macular telangiectasia type 2: comparison between SD-OCT and OCT angiography.
    Pauleikhoff D; Gunnemann F; Book M; Rothaus K
    Graefes Arch Clin Exp Ophthalmol; 2019 Jul; 257(7):1381-1392. PubMed ID: 31093765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radial Hemorrhage in Henle Layer in Macular Telangiectasia Type 2.
    Au A; Hou K; Baumal CR; Sarraf D
    JAMA Ophthalmol; 2018 Oct; 136(10):1182-1185. PubMed ID: 30054619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does size of telangiectasia on optical coherence tomography angiography influence vision in eyes with type 2 macular telangiectasia?
    Kelkar AS; Kelkar JA; Tidke S; Agarwal A; Bolisetty M; Kelkar S
    Indian J Ophthalmol; 2021 Dec; 69(12):3570-3576. PubMed ID: 34826997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative analysis of retinal microvascular changes in macular telangiectasia type 2 using optical coherence tomography angiography.
    Park YG; Park YH
    PLoS One; 2020; 15(4):e0232255. PubMed ID: 32348375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retinal vascular density evaluated by optical coherence tomography angiography in macular telangiectasia type 2.
    Dogan B; Erol MK; Akidan M; Suren E; Akar Y
    Int Ophthalmol; 2019 Oct; 39(10):2245-2256. PubMed ID: 30607862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SWEPT SOURCE OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY OF NEOVASCULAR MACULAR TELANGIECTASIA TYPE 2.
    Zhang Q; Wang RK; Chen CL; Legarreta AD; Durbin MK; An L; Sharma U; Stetson PF; Legarreta JE; Roisman L; Gregori G; Rosenfeld PJ
    Retina; 2015 Nov; 35(11):2285-99. PubMed ID: 26457402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fundus Autofluorescence Imaging in Macular Telangiectasia Type 2: MacTel Study Report Number 9.
    Pauleikhoff L; Heeren TFC; Gliem M; Lim E; Pauleikhoff D; Holz FG; Clemons T; Balaskas K; ; Egan CA; Charbel Issa P
    Am J Ophthalmol; 2021 Aug; 228():27-34. PubMed ID: 33775659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microvascular changes precede visible neurodegeneration in fellow eyes of patients with asymmetric type 2 macular telangiectasia.
    Chandran K; Giridhar A; Gopalakrishnan M; Sivaprasad S
    Eye (Lond); 2022 Aug; 36(8):1623-1630. PubMed ID: 34326496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tamoxifen Retinopathy and Macular Telangiectasia Type 2: Similarities and Differences on Multimodal Retinal Imaging.
    Hess K; Park YJ; Kim HA; Holz FG; Charbel Issa P; Yoon YH; Tzaridis S
    Ophthalmol Retina; 2023 Feb; 7(2):101-110. PubMed ID: 35948211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optical coherence tomography angiography findings of fellow eye of proliferative macular telangiectasia type 2: Long term study.
    Singh SR; Fraser-Bell S; Dogra A; Sahoo NK; Gabrielle PH; Lupidi M; Al-Sheikh M; Borrelli E; Sacconi R; Querques G; Chhablani J
    Eur J Ophthalmol; 2021 Jul; 31(4):1933-1939. PubMed ID: 32613846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics and quantification of vascular changes in macular telangiectasia type 2 on optical coherence tomography angiography.
    Chidambara L; Gadde SG; Yadav NK; Jayadev C; Bhanushali D; Appaji AM; Akkali M; Khurana A; Shetty R
    Br J Ophthalmol; 2016 Nov; 100(11):1482-1488. PubMed ID: 26823394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Staging of macular telangiectasia: power-Doppler optical coherence tomography and macular pigment optical density.
    Chin EK; Kim DY; Hunter AA; Pilli S; Wilson M; Zawadzki RJ; Werner JS; Park SS
    Invest Ophthalmol Vis Sci; 2013 Jul; 54(7):4459-70. PubMed ID: 23716628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optical Coherence Tomography Angiography in Monitoring Proliferative Macular Telangiectasia Type 2 Treatment Response.
    Estawro RG; Embabi SN
    Ophthalmic Surg Lasers Imaging Retina; 2019 Aug; 50(8):485-491. PubMed ID: 31415694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EARLY SPECTRAL-DOMAIN OPTICAL COHERENCE TOMOGRAPHY BIOMARKERS TO CONFIRM FELLOW EYE CHANGES IN ASYMMETRIC TYPE-2 MACULAR TELANGIECTASIA: A Case-Control Study (India Macular Telangiectasia Report 1).
    Alex D; Giridhar A; Gopalakrishnan M; Manayath G; Amar S; Raman R; Sreenivasan R; Ayachit A; Sivaprasad S
    Retina; 2021 Mar; 41(3):471-479. PubMed ID: 32804830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperpigmented epiretinal membrane in macular telangiectasia type 2: imaging characteristics and correlation with transretinal pigment migration.
    Cabral D; Ramtohul P; Kaden TR; Tenreiro S; Seabra MC; Freund KB
    Eye (Lond); 2023 Jun; 37(9):1856-1860. PubMed ID: 36138103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optical coherence tomography-angiography for monitoring neovascularisations in macular telangiectasia type 2.
    Tzaridis S; Hess K; Friedlander M; Holz FG
    Br J Ophthalmol; 2021 May; 105(5):735-740. PubMed ID: 32513667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.